GSK2816126
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2816126, covering 2019-06-28 to 2019-06-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma [Phase 1]